Cyberounds Logo
December 12, 2018 | LOGIN | REGISTER | HELP | 
email a friend print Bookmark and Share
Atherosclerosis in Systemic Lupus Erythematosus
CME credit is no longer available for this conference.
Ji Lee, M.D., Bernard Hojaili, M.D., Elena Peeva, M.D., and Peter Barland, M.D.

Dr. Peeva is Assistant Professor, Albert Einstein College of Medicine, and Dr. Hojaili is a member of the Department of Medicine, Jacobi Hospital in the Bronx, and the Rheumatology Division of the Albert Einstein College of Medicine. Dr. Lee is a resident at UMDJ-University Hospital, Newark, NJ.

The authors report no commercial conflicts of interest.


Release Date: 06/27/2005
Termination Date: 06/27/2008

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
Learning Objectives
Upon completion of this Cyberounds®, you should be able to:
  • Describe the inflammatory nature of atherosclerosis and implications of chronic inflammation in the development of premature atherosclerosis in SLE
  • Describe mechanisms involved in accelerated atherogenesis in lupus, as well as therapy-related factors that may contribute to development of premature atherosclerosis in SLE
  • Discuss preventive measures that may help reduce the risks of premature atherosclerosis in patients with SLE.

 
This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
 
Please click below to accept the terms of this CME activity